NewGenIvf Group Limited (NIVF)
| Market Cap | 5.23M |
| Revenue (ttm) | 5.68M |
| Net Income (ttm) | -80,775 |
| Shares Out | 13.59M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,254,547 |
| Open | 0.359 |
| Previous Close | 0.340 |
| Day's Range | 0.342 - 0.397 |
| 52-Week Range | 0.240 - 17.240 |
| Beta | -0.12 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 16, 2025 |
About NIVF
NewGenIvf Group Limited provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan. Its services includes mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, mrt techniques, in-vitro fertilization /ICSI, hysteroscopy, semen analysis, TESE/TESA/PESA, embryo transfer, egg freezing, and chromosome screening, as well as surrogacy and ancillary caring services. The company was founded in 2010 and is based in Central, Hong Kong. [Read more]
Financial Performance
In 2023, NewGenIvf Group's revenue was $5.14 million, a decrease of -13.59% compared to the previous year's $5.94 million. Earnings were $130,193, a decrease of -71.61%.
Financial numbers in USD Financial StatementsNews
NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline
BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today announced that both parties involved in the previously announced reverse merger with...
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance
Multiple strategic initiatives include applying to transfer to Nasdaq Capital Market, leveraging recent fundraising arrangements to boost equity Multiple strategic initiatives include applying to tran...
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price
BANGKOK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on October 8, 2024, the Company received a letter (the “Deficiency L...
NewGenIvf Announces Filing of 2023 Annual Report with the SEC
Total Revenues Reach US$5.1 Million Gross Profit Increases by 9.4% to US$1.7 Million Net Income of US$0.1 million
NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access...
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Value of Listed Securities
BANGKOK, May 28, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), today announced that on May 24, 2024, the Company received two letters from the Listing Qu...
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings
BANGKOK, Thailand, April 22, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals ob...
NewGenIvf and A SPAC I Announce Closing of Business Combination
NewGenIvf's shares and warrants are expected to begin trading on the Nasdaq Capital Market under the tickers "NIVF" and "NIVFW", respectively, on April 4, 2024 NEW YORK , April 3, 2024 /PRNewswire/ --...
NewGenIvf and A SPAC I Announce Shareholder Approval of Business Combination
Combined company to be named NewGenIvf Group Limited NEW YORK , March 5, 2024 /PRNewswire/ -- NewGenIvf Limited ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping...
NewGenIvf, a full-service fertility services provider in Asia, Announces Plans to List on Nasdaq Through Merger with A SPAC I Acquisition Corp.
NEW YORK , Feb. 16, 2023 /PRNewswire/ -- NewGenIvf Limited ("NewGen" or the "Company"), a full-service fertility services provider in Asia that aids couples and individuals, regardless of fertility ch...